900 Omnicare Center
201 East Fourth Street
Cincinnati OH 45202
*NOTE: This phone number and email address are for Sales inquiries, only. If you are a current customer with an operational or billing concern, please contact your local pharmacy.
Questions concerning Omnicare's operations and financial results should be directed to the Investor Relations Department at (800) DIAL-OCR (800-342-5627) or via email to firstname.lastname@example.org.
Requests for annual reports, press releases and other published information should be directed to (800) DIAL-OCR (800-342-5627) or via email to email@example.com. These documents can also be obtained in the Investor Relations section of our website.
For changes of address or information concerning transfer of stock, dividends or lost stock certificates, stockholders should contact BNY Mellon Shareowner Services at (800) 791-3932. The deaf and hearing-impaired may call (800) 231-5469.
Omnicare's common stock is listed on the New York Stock Exchange under the symbol OCR.
For concerns that are not urgent, you may also utilize the form below to contact Omnicare's corporate office. Please complete ALL fields to ensure that your inquiry reaches the correct department for follow-up.